199 related articles for article (PubMed ID: 15506047)
1. [Botulinum toxin type A treatment of upper limb spasticity].
Wissel M; Wissel J
Wien Klin Wochenschr; 2001; 113 Suppl 4():16-9. PubMed ID: 15506047
[TBL] [Abstract][Full Text] [Related]
2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
3. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity.
Suputtitada A; Suwanwela NC
Disabil Rehabil; 2005 Feb; 27(4):176-84. PubMed ID: 15824048
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of the spastic drop foot with botulinum toxin type A in adult patients].
Voller B; Földy D; Hefter H; Auff E; Schnider P
Wien Klin Wochenschr; 2001; 113 Suppl 4():25-9. PubMed ID: 15506049
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
Slawek J; Bogucki A; Reclawowicz D
Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
[TBL] [Abstract][Full Text] [Related]
7. Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb.
Turner-Stokes L; Ashford S
Disabil Rehabil; 2007 Dec; 29(23):1806-12. PubMed ID: 18033605
[TBL] [Abstract][Full Text] [Related]
8. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
Ashford S; Turner-Stokes L
Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366
[TBL] [Abstract][Full Text] [Related]
9. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
10. [Measuring outcome in spasticity rehabilitation].
Fheodoroff K; Wissel J; Entner T; Freimüller M
Wien Klin Wochenschr; 2001; 113 Suppl 4():11-5. PubMed ID: 15506046
[TBL] [Abstract][Full Text] [Related]
11. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
Yablon SA; Brashear A; Gordon MF; Elovic EP; Turkel CC; Daggett S; Liu J; Brin MF
Clin Ther; 2007 Apr; 29(4):683-90. PubMed ID: 17617291
[TBL] [Abstract][Full Text] [Related]
12. [Botulinum toxin type A in the treatment plan for cerebral palsy].
Strobl W
Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
[TBL] [Abstract][Full Text] [Related]
13. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
[TBL] [Abstract][Full Text] [Related]
14. [Botulinum toxin: a new dimension for spasticity].
Reichel G
MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
Fève A; Decq P; Filipetti P; Kéravel Y
Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
[TBL] [Abstract][Full Text] [Related]
16. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
Lam K; Lau KK; So KK; Tam CK; Wu YM; Cheung G; Liang KS; Yeung KM; Lam KY; Yui S; Leung C
J Am Med Dir Assoc; 2012 Jun; 13(5):477-84. PubMed ID: 22521630
[TBL] [Abstract][Full Text] [Related]
17. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia.
Mayer NH; Whyte J; Wannstedt G; Ellis CA
Arch Phys Med Rehabil; 2008 May; 89(5):982-7. PubMed ID: 18452749
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
Jost WH; Hefter H; Reissig A; Kollewe K; Wissel J
J Neurol Sci; 2014 Feb; 337(1-2):86-90. PubMed ID: 24361062
[TBL] [Abstract][Full Text] [Related]
20. Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A.
Guettard E; Roze E; Abada G; Lemesle C; Vidailhet M; Laurent-Vannier A; Chevignard MP
Dev Neurorehabil; 2009 Jun; 12(3):128-38. PubMed ID: 19466620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]